Benitec Biopharma Inc.
BNTC
$-0.43
Change (1 day)
$12.89
Year High
$2.69
Year Low
Categories
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Dividend history for Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.00
Dividend payments for Benitec Biopharma Inc. (BNTC) from 2018 to 2018
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| June 01, 18 | $0.00 | $0.77 |